Journal profile · Peripheral Vascular Disease
Journal of Thrombosis and Thrombolysis
ISSN 0929-5305 · eISSN 1573-742X · Springer US · NETHERLANDS · Bimonthly · Founded 1994
Journal of Thrombosis and Thrombolysis: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.07; hybrid open access; APC about USD 3,890; median 89 days to acceptance (64 articles, last 24 months); community-reported acceptance: easy; 159 articles in 2025; indexed in SCIE and Scopus.
The journal's website announces a move to full open access: We are pleased to announce that Journal of Thrombosis and Thrombolysis will become a fully open access (OA) on 1 January 2027. Source ↗Publisher website ·
Scope
Aims, scope and focus
Journal of Thrombosis and Thrombolysis is published by Springer US and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes and Acute Myocardial Infarction Research, together about 46.4% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Announcement We are pleased to announce that Journal of Thrombosis and Thrombolysis will become a fully open access (OA) on 1 January 2027. As a result, all submissions received from 8 September 2026 are subject to an article publication charge (APC) if accepted and published in the journal (unless a waiver is applied). Please see our FAQs which can be found at the bottom of this page for more information on APCs, funding options, waivers and the journal's transition to fully open access. The Journal of Thrombosis and Thrombolysis is a long-awaited resource for contemporary cardiologists, hematologists, vascular medicine specialists and clinician-scientists actively involved in treatment decisions and clinical investigation of thrombotic disorders involving the cardiovascular and cerebrovascular systems. The principal focus of the Journal centers on the pathobiology of thrombosis and vascular disorders and the use of anticoagulants, platelet antagonists, cell-based therapies and interventions in scientific investigation, clinical-translational research, population science and patient care. In keeping with our commitment to contemporary topics and scientific advance on a global scale, the Journal has established a section dedicated to the COVID-19 pandemic with an accelerated peer review, decision, and publication of scholarly review papers, observational studies and randomized clinical trials that will inform scientific undertakings and patient management.The Journal will publish original work which emphasizes the interface between fundamental scientific principles and clinical investigation, stimulating an interdisciplinary and scholarly dialogue in thrombosis and vascular medicine. Published works will also define platforms for translational research, drug development, clinical trials, new drugs and devices, and patient-directed applications. The Journal of Thrombosis and Thrombolysis' integrated format will expand the reader's knowledge base and provide important insights for both the investigation and direct clinical application of the most rapidly growing fields in medicine-thrombosis and vascular medicine.The Journal seeks original manuscripts devoted to fundamental science in cardiovascular disease, laboratory investigation, pharmacogenetics, clinical research, global health, population science, and epidemiology. State-of-the-art reviews, position papers and editorials will be summoned by invitation from the editor or an appointed guest editor. The
From the journal's Aims & Scope
Research area (LetPub): Peripheral Vascular Disease
Editor-in-chief Diana A. GorogPublisher website
Editorial board by country: none in mainland China; most named United States 24, United Kingdom 6, Italy 6, Germany 4, Australia 4 (57 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Venous Thromboembolism Diagnosis and ManagementMedicine21.8%
- Atrial Fibrillation Management and OutcomesMedicine14.9%
- Acute Myocardial Infarction ResearchMedicine9.7%
- Antiplatelet Therapy and Cardiovascular DiseasesMedicine8.3%
- Blood Coagulation and Thrombosis MechanismsMedicine6.8%
- Acute Ischemic Stroke ManagementMedicine4.5%
- Platelet Disorders and TreatmentsMedicine3.8%
- Heparin-Induced Thrombocytopenia and ThrombosisMedicine3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
| Minor | Hematology | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.07LetPub ·
- Impact factor (publisher) 2025
- 2.1Publisher website ·
- 5-year impact factor (publisher) 2025
- 2Publisher website ·
- CiteScore 2026-06
- 4.9LetPub ·
- SJR 2026-06
- 0.65LetPub ·
- SNIP 2026-06
- 0.78LetPub ·
- h-index
- 59LetPub ·
- h-index
- 97OpenAlex ·
- i10-index
- 2,004OpenAlex ·
- 2-year mean citedness
- 2.08OpenAlex ·
- Self-citation rate
- 4.8%LetPub ·
- Share of gold OA articles
- 31.91%LetPub ·
Volume
- Articles per year
- 150LetPub ·
- Downloads per year (publisher) 2025
- 679,700Publisher website ·
Articles by year OpenAlex count · 4,258 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 170 | 58 | 53 |
| 2025 | 159 | 67 | 322 |
| 2024 | 139 | 54 | 600 |
| 2023 | 167 | 68 | 1,008 |
| 2022 | 142 | 55 | 1,440 |
| 2021 | 269 | 132 | 3,424 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
89 daysMedian, submission to acceptance · P25–P75 71 days – 125 days
- Acceptance to online
- median 17 days (99 articles)
- Submission to online
- median 116 days
- Sample
- 64 articles with submission and acceptance dates (352 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 3 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,890 / EUR 3,190 / GBP 2,590 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare9 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 5,000 words
- Reference style
- Numbered, in order of citation
- Templates
- LaTeX
- Suggested reviewers
- Required
- Highlights
- Required
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted11, with length limits
- brief communicationWhen submitting, please select from the following Article Types: ResearchReviewBrief ReportCorrespondenceEditorialCommentObituary Cover Letter Authors submittin…main text ≤ 1,500 words
- brief reportWhen submitting, please select from the following Article Types: Research Review Brief Report Correspondence Editorial Comment ObituaryLength not stated
- commentWhen submitting, please select from the following Article Types: Research Review Brief Report Correspondence Editorial Comment ObituaryLength not stated
- correspondenceWhen submitting, please select from the following Article Types: Research Review Brief Report Correspondence Editorial Comment ObituaryLength not stated
- editorialWhen submitting, please select from the following Article Types: ResearchReviewBrief ReportCorrespondenceEditorialCommentObituary Cover Letter Authors submittin…Length not stated
- hypothesisWhen submitting, please select from the following Article Types: ResearchReviewBrief ReportCorrespondenceEditorialCommentObituary Cover Letter Authors submittin…Length not stated
- letterWhen submitting, please select from the following Article Types: ResearchReviewBrief ReportCorrespondenceEditorialCommentObituary Cover Letter Authors submittin…Length not stated
- obituaryWhen submitting, please select from the following Article Types: Research Review Brief Report Correspondence Editorial Comment ObituaryLength not stated
- researchWhen submitting, please select from the following Article Types: Research Review Brief Report Correspondence Editorial Comment ObituaryLength not stated
- reviewWhen submitting, please select from the following Article Types: ResearchReviewBrief ReportCorrespondenceEditorialCommentObituary Cover Letter Authors submittin…main text ≤ 5,000 words
- review articleWhen submitting, please select from the following Article Types: ResearchReviewBrief ReportCorrespondenceEditorialCommentObituary Cover Letter Authors submittin…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
Manuscripts must be original, not under consideration elsewhere, and approved by all co-authors and responsible authorities. Model summary
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
The journal is a COPE member and follows COPE guidelines on misconduct. Model summary
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Permission from copyright owners is required for previously published figures, tables, or text passages. Model summary
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Journal of Thrombosis and Thrombolysis, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Authors should suggest two independent reviewers and may request exclusion of up to two reviewers; editors are not obliged to fulfill these requests. Model summary
Authors submitting their research to Journal of Thrombosis and Thrombolysis are kindly asked to suggest two independent reviewers on the cover letter of their submission. Authors may also request to exclude a maximum of two reviewers from consideration. Editors will consider these requests, but are not obliged to fulfill them. The Editor's decision on the choice of peer reviewers is final.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1994
- ISSN
- 0929-5305
- Electronic ISSN
- 1573-742X
- Latest issue on the website
- Volume 59, Issue 6 (August 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Thrombosis and Thrombolysis
What CAS zone is Journal of Thrombosis and Thrombolysis in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Thrombosis and Thrombolysis is in Zone 3 of Medicine, and in Zone 3 of the minor category Hematology / Cardiac & Cardiovascular Systems / Peripheral Vascular Disease. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Thrombosis and Thrombolysis?
The latest impact factor listed by LetPub is 2.07; CiteScore 4.9, h-index 97.
How long does peer review take at Journal of Thrombosis and Thrombolysis?
Based on the dates recorded on 64 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 89 days (interquartile range 71–125 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Thrombosis and Thrombolysis?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 5,000 words; Reference style: Numbered, in order of citation; Templates: LaTeX; Suggested reviewers: Required; Highlights: Required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Thrombosis and Thrombolysis based?
Of the 57 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (24), United Kingdom (6) and Italy (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Thrombosis and Thrombolysis?
According to LetPub and DOAJ records, Journal of Thrombosis and Thrombolysis is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Journal of Thrombosis and Thrombolysis open access, and what is the APC?
Journal of Thrombosis and Thrombolysis is a hybrid journal. For open-access publication: APC about USD 3,890.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .